Antifungal Drugs in Pulmonary Mucormycosis

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

312

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

July 10, 2025

Study Completion Date

December 31, 2026

Conditions

Pulmonary Mucormycosis

Interventions

DRUG

Combination therapy group

Liposomal amphotericin B (AmBisome®) combination with Isavuconazole

DRUG

Liposomal Amphotericin B

Liposomal amphotericin B (AmBisome®) alone

All Listed Sponsors

lead

Bin Cao

OTHER